Gallagher Neil - Insider Non-Derivative Transactions at Syndax Pharmaceuticals Inc (SNDX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 7, 2024, Gallagher Neil's relationship to Syndax Pharmaceuticals Inc (SNDX) is Officer (President, Head of R&D), and currently has 47,813 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SNDX insiders.
Data Source: SEC.
Gallagher Neil - Insider Non-Derivative Transactions at SNDX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 8, 2024 | Acquisition -- (Common Stock) | 34688 | 0 | 34688 |
| Feb 8, 2024 | Acquisition -- (Common Stock) | 13125 | 0 | 47813 |